1 / 5

sanofi pasteur’s Perspective on Universal Influenza Vaccination

sanofi pasteur’s Perspective on Universal Influenza Vaccination. Universal Vaccination Against Influenza – Are We Ready? Atlanta, Georgia October 25, 2005 Phil Hosbach Vice President Immunization Policy and Government Relations Swiftwater, Pennsylvania. Company Perspective.

breck
Download Presentation

sanofi pasteur’s Perspective on Universal Influenza Vaccination

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. sanofi pasteur’s Perspective on Universal Influenza Vaccination Universal Vaccination Against Influenza – Are We Ready? Atlanta, Georgia October 25, 2005 Phil Hosbach Vice President Immunization Policy and Government Relations Swiftwater, Pennsylvania

  2. Company Perspective • Universal recommendation will be positive step in expanding influenza immunization rates • But will not be a panacea • Success of recommendation implementation is dependent on public-private partnership • Industry, government, healthcare community • Manufacturers are investing in expanding capacity • Anticipate stepped approach to universal recommendation implementation with gradual supply increase • To further increase vaccine development: • Important to recognize value of vaccines to ensure ROI • Increase stability of influenza vaccine market • Reduce manufacturer liability exposure by strengthening VICP

  3. Company Perspective • Government must recognize that demand will drive supply • Unused vaccine won’t stimulate production • Healthcare community must be more engaged • Must do better job of getting immunized • Must improve communicating importance to patients

  4. Investment in Influenza Immunization • Sanofi pasteur currently will produce approximately 60 million doses of vaccine this year • Company produced ~58 million doses in 2004-2005 • Company has invested in $150 million, 145,000 square foot addition at its U.S. headquarters in Swiftwater, Pa. • Will double U.S. capacity for influenza vaccine to ~100 million doses per year • Expected to be approved for 2009-2010 influenza season

  5. Summary • Sanofi pasteur is strong supporter of universal recommendation • Important to recognize industry is only part of the solution and entire vaccine enterprise needs to play role • Commitment and action from US government and healthcare community is essential for success of recommendation as well as industry stability

More Related